Edition:
United States

TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

5.50USD
1:26pm EDT
Change (% chg)

$-0.06 (-1.08%)
Prev Close
$5.56
Open
$5.57
Day's High
$5.69
Day's Low
$5.45
Volume
322,991
Avg. Vol
580,089
52-wk High
$7.66
52-wk Low
$4.34

Chart for

About

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials... (more)

Overall

Beta: 0.95
Market Cap(Mil.): $1,082.14
Shares Outstanding(Mil.): 216.43
Dividend: --
Yield (%): --

Financials

  TXMD.OQ Industry Sector
P/E (TTM): -- 30.91 33.65
EPS (TTM): -0.45 -- --
ROI: -68.00 14.75 14.28
ROE: -68.00 16.25 16.00

TherapeuticsMD's therapy for menopause-related condition gets approval

Women's healthcare company TherapeuticsMD Inc won its first-ever U.S. approval on Wednesday with the drug regulator clearing its hormone therapy for a painful condition triggered by menopause after rejecting it a year earlier.

May 30 2018

UPDATE 2-TherapeuticsMD's therapy for menopause-related condition gets approval

* Shares volatile; last down 2 pct (Adds analyst, CEO comment, share movement)

May 30 2018

FDA approves TherapeuticsMD's hormone therapy

May 30 The U.S. Food and Drug Administration approved TherapeuticsMD Inc's hormone therapy for a painful condition triggered by menopause, the women's health company said on Wednesday.

May 30 2018

BRIEF-Therapeutics MD Reports Loss Per Share Of $0.11

* THERAPEUTICSMD ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

May 03 2018

Earnings vs. Estimates